You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 7,829,537


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,829,537
Title:Receptor associated protein (RAP) conjugates
Abstract: The present invention is directed to a methods and compositions for receptor mediated drug delivery, particularly across the blood-brain barrier.
Inventor(s): Zankel; Todd C. (San Francisco, CA), Starr; Christopher M. (Sonoma, CA)
Assignee: Raptor Pharmaceuticals Inc. (Novato, CA)
Application Number:12/508,956
Patent Claims:1. A conjugate comprising a receptor associated protein (RAP) polypeptide and a therapeutic or diagnostic/investigational agent, wherein the RAP polypeptide consists of an amino acid sequence at least 80% identical to amino acids 221-323 of RAP (SEQ ID NO: 1).

2. The conjugate of claim 1, wherein the therapeutic agent is a chemotherapeutic agent.

3. The conjugate of claim 2, wherein the chemotherapeutic agent is selected from the group consisting of an alkylating agent, an alkaloid, an anti-metabolite, an antibiotic, and an anti-proliferative agent.

4. The conjugate of claim 3, wherein the chemotherapeutic agent is selected from the group consisting of Mechlorethamine hydrochloride, Cyclophosphamide, Ifosfamide, Chlorambucil, Melphalan, Busulfan, Thiotepa (Triethylenethiophosphoramide), Carmustine, Lomustine, Streptozocin, Vincristine, Vinblastine, Paclitaxel, Methotrexate, Mercaptopurine, Thioguanine, Fluorouracil, Cytarabine, Azacitidine, Dactinomycin, Doxorubicin, Daunorubicin, Idarubicin, Bleomycin, Picamycin, Mitomycin, Hydroxyurea, Procarbazine, Dacarbazine, Cisplatin, Carboplatin, Asparaginase, Etoposide, Amsarcrine, Mitotane, and Mitoxantrone.

5. The conjugate of claim 1, wherein the therapeutic agent is a neurotrophic factor.

6. The conjugate of claim 5, wherein the therapeutic agent is a neurotrophic factor selected from the group consisting of Glial-Derived Neurotrophic Factor, Nerve Growth Factor, Brain-Derived Neurotrophic Factor, Neurotrophin-3, Neurotrophin-4/5, aFGF, bFGF, CNTF, Leukemia Inhibitory Factor, Cardiotrophin-1, TGF.beta., BMPs, GDFs, Neurturin, Artemin, Persephin, EGF, TGF.alpha., Neuregulins, IGF-1, IGF-2, ADNF and PDGF.

7. The conjugate of claim 6, wherein the therapeutic agent is brain-derived neurotrophic factor (BDNF).

8. The conjugate of claim 2, wherein the agent is a diagnostic/investigational agent and comprises a detectable label.

9. The conjugate of claim 1, wherein the agent is conjugated to the RAP amino acid sequence via covalent bonding.

10. The conjugate of claim 1, wherein the agent is conjugated to the RAP amino acid sequence via a peptide linker.

11. The conjugate of claim 1, wherein said RAP polypeptide is further missing the endoplasmic reticulum retention signal at residues 320-323 of SEQ ID NO: 1.

12. The conjugate of claim 1, wherein the conjugate is a fusion protein of the RAP polypeptide and a therapeutic agent.

13. A sterile composition comprising the conjugate of any one of claim 1, 2, 3 or 5 and a pharmaceutically acceptable carrier.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.